Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Jones

Showing results (101-110 of 151) with videos related to

Pageof 16
Sort By:
Leukemia & Lymphoma|November 9, 2018
Evaluation of the CLL-IPI in relapsed and refractory chronic lymphocytic leukemia in idelalisib phase-3 trialsJacob D Soumerai, Ai Ni, Guan Xing, et al.
Pain|October 9, 2015
CRHBP polymorphisms predict chronic pain development following motor vehicle collisionSarah D Linnstaedt, Andrey V Bortsov, April C Soward, et al.
Molecular Psychiatry|February 1, 2024
Human iN neuronal model of schizophrenia displays dysregulation of chromogranin B and related neuropeptide transmitter signaturesSonia Podvin, Jeffrey Jones, Austin Kang, et al.
Stem Cell Reports|October 2, 2018
Fast Generation of Functional Subtype Astrocytes from Human Pluripotent Stem CellsXiang Li, Yezheng Tao, Robert Bradley, et al.
Blood|March 8, 2011
The role of phosphatidylinositol 3-kinase-δ in the immunomodulatory effects of lenalidomide in chronic lymphocytic leukemiaSarah E M Herman, Rosa Lapalombella, Amber L Gordon, et al.
Pain|January 26, 2016
Chronic widespread pain after motor vehicle collision typically occurs through immediate development and nonrecovery: results of an emergency department-based cohort studyJunMei Hu, Andrey V Bortsov, Lauren Ballina, et al.
Blood|March 23, 2011
Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765Sarah E M Herman, Amber L Gordon, Erin Hertlein, et al.
Blood|August 24, 2021
Phase 1 study of oral azacitidine (CC-486) plus R-CHOP in previously untreated intermediate- to high-risk DLBCLPeter Martin, Nancy L Bartlett, Julio C Chavez, et al.
ACS Medicinal Chemistry Letters|April 25, 2017
Discovery of Highly Selective Inhibitors of the Immunoproteasome Low Molecular Mass Polypeptide 2 (LMP2) SubunitHenry W B Johnson, Janet L Anderl, Erin K Bradley, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 1, 2010
Effect of specimen storage conditions on newborn dried blood spots used to assess Toxoplasma gondii immunoglobulin M (IgM)Joanne V Mei, LiXia Li, Sonja A Rasmussen, et al.
Pageof 16

Showing results (101-110 of 151) with videos related to

Sort By:
Pageof 16
Leukemia & Lymphoma|November 9, 2018
Evaluation of the CLL-IPI in relapsed and refractory chronic lymphocytic leukemia in idelalisib phase-3 trialsJacob D Soumerai, Ai Ni, Guan Xing, et al.
Pain|October 9, 2015
CRHBP polymorphisms predict chronic pain development following motor vehicle collisionSarah D Linnstaedt, Andrey V Bortsov, April C Soward, et al.
Molecular Psychiatry|February 1, 2024
Human iN neuronal model of schizophrenia displays dysregulation of chromogranin B and related neuropeptide transmitter signaturesSonia Podvin, Jeffrey Jones, Austin Kang, et al.
Stem Cell Reports|October 2, 2018
Fast Generation of Functional Subtype Astrocytes from Human Pluripotent Stem CellsXiang Li, Yezheng Tao, Robert Bradley, et al.
Blood|March 8, 2011
The role of phosphatidylinositol 3-kinase-δ in the immunomodulatory effects of lenalidomide in chronic lymphocytic leukemiaSarah E M Herman, Rosa Lapalombella, Amber L Gordon, et al.
Pain|January 26, 2016
Chronic widespread pain after motor vehicle collision typically occurs through immediate development and nonrecovery: results of an emergency department-based cohort studyJunMei Hu, Andrey V Bortsov, Lauren Ballina, et al.
Blood|March 23, 2011
Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765Sarah E M Herman, Amber L Gordon, Erin Hertlein, et al.
Blood|August 24, 2021
Phase 1 study of oral azacitidine (CC-486) plus R-CHOP in previously untreated intermediate- to high-risk DLBCLPeter Martin, Nancy L Bartlett, Julio C Chavez, et al.
ACS Medicinal Chemistry Letters|April 25, 2017
Discovery of Highly Selective Inhibitors of the Immunoproteasome Low Molecular Mass Polypeptide 2 (LMP2) SubunitHenry W B Johnson, Janet L Anderl, Erin K Bradley, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 1, 2010
Effect of specimen storage conditions on newborn dried blood spots used to assess Toxoplasma gondii immunoglobulin M (IgM)Joanne V Mei, LiXia Li, Sonja A Rasmussen, et al.
Pageof 16